-
公开(公告)号：EP0832135A1
公开(公告)日：1998-04-01
申请号：EP96923279.0
申请日：1996-06-07
申请人： MEDAREX, INC.
CPC分类号： C07K16/2863 , A61K38/00 , C07K14/33 , C07K14/485 , C07K16/283 , C07K16/3007 , C07K16/32 , C07K2317/24 , C07K2317/73 , C07K2317/732 , C07K2319/00
摘要： Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and methods for making the molecules are described.
-
公开(公告)号：EP1212366B1
公开(公告)日：2007-09-12
申请号：EP00948934.5
申请日：2000-07-25
申请人： MEDAREX, INC.
IPC分类号： C07K19/00 , A61K39/395 , A61P35/00 , C07K16/28 , C07K14/485
CPC分类号： C07K16/283 , A61K38/1808 , A61K2039/505 , C07K14/485 , C07K16/2863 , C07K16/32 , C07K2317/24 , C07K2317/31 , C07K2317/51 , C07K2317/55 , C07K2317/732 , C07K2317/77 , C07K2319/00
摘要： Multispecific molecules which induce effector cell-mediated killing of target cells are disclosed. The molecules are 'multispecific' because they bind to multiple (two or more), distinct targets, one of which is an Fc receptor on the surface of an immune cell. Multispecific molecules of the invention include molecules comprised of at least one portion which binds to an Fc receptor, such as an Fcη receptor (e.g., FcηRI) or an Fcα receptor, and at least one other portion which binds to a different target, such as an antigen on a tumor cell or a pathogen. Multispecific molecules of the invention also include antigen 'multimer complexes' comprised of multiple (i.e., two or more) portions which bind to a molecule on an antigen presenting cell (APC), such as an Fc receptor, linked to one or more antigens. These multimer complexes target antigens, such as self-antigens, to APCs to induce and/or enhance internalization (endocytosis), processing and/or presentation of the antigen by the APC. Therefore, these molecules can be used to induce or enhance an immune response either in vivo or in vitro against a normally non-immunogenic protein, such as a self-antigen. In a particular embodiment, at least one portion of the multispecific molecules comprises a humanized or human antibody or antibody fragment (e.g., ScFv or Fab') which binds to an Fc receptor or a receptor on a target cell (e.g., EGF-R or HER2).
-
公开(公告)号：EP1044263A2
公开(公告)日：2000-10-18
申请号：EP98960647.0
申请日：1998-12-02
申请人： MEDAREX, INC.
CPC分类号： A61K39/0011 , A61K38/00 , A61K2039/5152 , A61K2039/5156 , C07K14/71 , C07K16/283 , C07K2317/54 , C07K2317/622 , C07K2317/732 , C07K2317/77 , C07K2319/00
摘要： Cells transformed to express on their surface a component which binds to an Fc receptor of an effector cell are disclosed. Also disclosed are expression vectors used to transform the cells. Once transformed, the cells bind to effector cells via the Fc receptor of the effector cell to stimulate an effector cell mediated immune response.
-
公开(公告)号：EP1212366A2
公开(公告)日：2002-06-12
申请号：EP00948934.5
申请日：2000-07-25
申请人： Medarex, Inc.
IPC分类号： C07K19/00 , A61K39/395 , A61P35/00
CPC分类号： C07K16/283 , A61K38/1808 , A61K2039/505 , C07K14/485 , C07K16/2863 , C07K16/32 , C07K2317/24 , C07K2317/31 , C07K2317/51 , C07K2317/55 , C07K2317/732 , C07K2317/77 , C07K2319/00
摘要： Multispecific molecules which induce effector cell-mediated killing of target cells are disclosed. The molecules are 'multispecific' because they bind to multiple (two or more), distinct targets, one of which is an Fc receptor on the surface of an immune cell. Multispecific molecules of the invention include molecules comprised of at least one portion which binds to an Fc receptor, such as an Fcη receptor (e.g., FcηRI) or an Fcα receptor, and at least one other portion which binds to a different target, such as an antigen on a tumor cell or a pathogen. Multispecific molecules of the invention also include antigen 'multimer complexes' comprised of multiple (i.e., two or more) portions which bind to a molecule on an antigen presenting cell (APC), such as an Fc receptor, linked to one or more antigens. These multimer complexes target antigens, such as self-antigens, to APCs to induce and/or enhance internalization (endocytosis), processing and/or presentation of the antigen by the APC. Therefore, these molecules can be used to induce or enhance an immune response either in vivo or in vitro against a normally non-immunogenic protein, such as a self-antigen. In a particular embodiment, at least one portion of the multispecific molecules comprises a humanized or human antibody or antibody fragment (e.g., ScFv or Fab') which binds to an Fc receptor or a receptor on a target cell (e.g., EGF-R or HER2).
-
-
-
搜索结果
4 条记录 (耗时 0.018 秒)
